<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54812</article-id><article-id pub-id-type="doi">10.7554/eLife.54812</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>CB<sub>1</sub> receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-170076"><name><surname>Monday</surname><given-names>Hannah R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170077"><name><surname>Bourdenx</surname><given-names>Mathieu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-170078"><name><surname>Jordan</surname><given-names>Bryen A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-169799"><name><surname>Castillo</surname><given-names>Pablo E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9834-1801</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Dominick P Purpura Department of Neuroscience</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Developmental and Molecular Biology, Institute for Aging Studies</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Dominick P Purpura Department of Neuroscience, Department of Psychiatry and Behavioral Sciences</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1202"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Reviewing editor</role><aff><institution>Oregon Health and Science University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>pablo.castillo@einsteinmed.org</email> (PC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>09</day><month>09</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e54812</elocation-id><history><date date-type="received"><day>30</day><month>12</month><year>2019</year></date><date date-type="accepted"><day>08</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Monday et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Monday et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54812-v1.pdf"/><abstract><p>Long-lasting forms of postsynaptic plasticity commonly involve protein synthesis-dependent structural changes of dendritic spines. However, the relationship between protein synthesis and presynaptic structural plasticity remains unclear. Here, we investigated structural changes in cannabinoid-receptor 1 (CB<sub>1</sub>)-mediated long-term depression of inhibitory transmission (iLTD), a form of presynaptic plasticity that involves a protein synthesis-dependent long-lasting reduction in GABA release. We found that CB<sub>1</sub>-iLTD in acute rat hippocampal slices was associated with protein synthesis-dependent presynaptic structural changes. Using proteomics, we determined that CB<sub>1</sub> activation in hippocampal neurons resulted in increased ribosomal proteins and initiation factors, but decreased levels of proteins involved in regulation of the actin cytoskeleton, such as ARPC2 and WASF1/WAVE1, and presynaptic release. Moreover, while CB<sub>1</sub>-iLTD increased ubiquitin/proteasome activity, ubiquitination but not proteasomal degradation was critical for structural and functional presynaptic CB<sub>1</sub>-iLTD. Thus, CB<sub>1</sub>-iLTD relies on both protein synthesis and ubiquitination to elicit structural changes that underlie long-term reduction of GABA release.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Rat</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>F31MH114431</award-id><principal-award-recipient><name><surname>Monday</surname><given-names>Hannah R</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01-MH081935</award-id><principal-award-recipient><name><surname>Castillo</surname><given-names>Pablo E</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000026</institution-id><institution>National Institute on Drug Abuse</institution></institution-wrap></funding-source><award-id>R01-DA17392</award-id><principal-award-recipient><name><surname>Castillo</surname><given-names>Pablo E</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01-NS113600</award-id><principal-award-recipient><name><surname>Castillo</surname><given-names>Pablo E</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id><institution>National Institute on Aging</institution></institution-wrap></funding-source><award-id>R01-AG039521</award-id><principal-award-recipient><name><surname>Jordan</surname><given-names>Bryen A</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Rainwater Charitable Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Bourdenx</surname><given-names>Mathieu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Experimental procedures adhered to NIH and Albert Einstein College of Medicine Institutional Animal Care and Use Committee guidelines as approved by protocol #00001047.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated in this study are included in the manuscript and supporting files. Source data files are provided for Figure 2.The mass spectrometry proteomics data have been deposited to the ProteomeX change with identifier Consortium via the PRIDE [1] partner repository with the dataset identifier PXD020008 and 10.6019/PXD020008.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Monday HR</collab><collab>Bourdenx M</collab><collab>Jordan BA</collab><collab>Castillo PE</collab></person-group><year iso-8601-date="2020">2020</year><source>CB1 receptor-mediated inhibitory LTD triggers presynaptic remodeling via protein synthesis and ubiquitination</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD020008">https://www.ebi.ac.uk/pride/archive/projects/PXD020008</ext-link><comment>PRIDE, PXD020008</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Akimov V</collab><collab>Barrio-Hernandez I</collab><collab>Hansen SVF</collab><collab>Hallenborg P</collab><collab>Pedersen AK</collab><collab>Bekker-Jensen DB</collab><collab>Puglia M</collab><collab>Christensen SDK</collab><collab>Vanselow JT</collab><collab>Nielsen MM</collab></person-group><year iso-8601-date="2018">2018</year><source>UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites.</source><ext-link ext-link-type="uri" xlink:href="http://csb.cse.yzu.edu.tw/UbiSite/">http://csb.cse.yzu.edu.tw/UbiSite/</ext-link><comment>UbiSite, https://doi.org/10.1038/s41594-018-0084-y</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>The UniProt Consortium</collab></person-group><year iso-8601-date="2018">2018</year><source>UniProt: the universal protein knowledgebase</source><ext-link ext-link-type="uri" xlink:href="Uniprot.org">Uniprot.org</ext-link><comment>Uniprot, Nucleic Acids Res 46: 2699 (2018)</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-54812-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>